Healthcare

OUE Lippo Healthcare reverses losses in 2021

The company's yearly earnings came in at $111m, compared to a loss of $98.7m in 2020.

OUE Lippo Healthcare reverses losses in 2021

The company's yearly earnings came in at $111m, compared to a loss of $98.7m in 2020.

Moderna announces Singapore expansion

Its new subsidiary will provide a local presence for improved logistics.

Singapore approves Pfizer's oral med Paxlovid for COVID treatment

Paxlovid is the first oral tablet in the country approved for the treatment of COVID-19.

US CDC updates travel warning against SG, PH

The warning has risen to 'Level Four: Very High.'

1 in 3 elderly unprepared for living with endemic COVID-19

An SMU study suggests that unpreparedness is linked with government trust.

Social distancing measures to see 14-day extension

The period covered will be from January 21 - February 20, 2022.

Econ Healthcare’s investment policy to undergo review

This comes after the company booked a loss of $3.4m from its Crosstec exit.

Econ Healthcare to book $3.4m loss in Crosstec exit

The loss will not have any material impact on the company.

Stay Home Notice not yet essential for travelers - Iswaran

The focus will be on enhancing tests and limiting VTL arrivals.

SG to provide US CDC with data after ‘unknown’ COVID level classification

MOH clarified the government knows Singapore’s COVID situation “very well.”

OUE Lippo appoints new COO

Joelle Lee Siew Hong will be responsible for the overall operations of the company.

STGT pushes Vietnam presence with new office

Its expansion will oversee the distribution of the group’s products in Vietnam.

Japanese firms embrace technological advancements to make positive impact

Azbil Corporation strengthens businesses in the Asia Pacific with a focus on the UN's SDGs; whilst Kyowa Kirin's cutting-edge science raises health...

MOH grants Acumen Diagnostics offsite PCR testing license

The testing services will be rolled out through Q&M Dental Group.

SG acquires AstraZeneca's Evusheld

Evusheld is a long-acting antibody candidate for COVID-19 treatment.